39 results
Elagolix (Orilissa) - Pharmacology Review
Elagolix is a small-molecule GnRH antagonist recently approved by the FDA for
Review Elagolix ... the FDA for the treatment ... #Pharmacology #Elagolix ... #Orilissa #Review ... #Overview
Warfarin color-coded tablets, initial dosing and INR targets

#pharmacology #overview #review #medications #drugs #cardiology #warfarin #management
INR targets #pharmacology ... #overview #review ... medications #drugs #cardiology
Alprazolam - short-acting benzodiazepine (GABA Receptor Modulator) used in the treatment of anxiety disorders. FDA approved
Modulator) used in the treatment ... #Pharmacology #Alprazolam ... #Xanax #Overview ... #Review
Metformin - oral antihyperglycemic agent for treatement of type II diabetes. 8th most prescribed drug in
antihyperglycemic agent for treatement ... #Pharmacology #Metformin ... Fortamet #AMPK #Overview ... #Review
Amlodipine - calcium channel blocker for the treatment of hypertension and CAD. 5th most prescribed drug
blocker for the treatment ... #Pharmacology #Amlodipine ... CalciumChannelBlocker #CCB #Overview ... #Review
Lisinopril - ACE inhibitor used for the treatment of hypertension and heart failure. 3rd most prescribed
inhibitor used for the treatment ... #Pharmacology #Lisinopril ... AngiotensinConvertingEnzyme #Inhibitor #Overview ... #Review
Cholecystitis - Diagnosis and Management Overview
Types - Acute Calculous, Acalculous, Xanthogranulomatous (chronic)
Complications 
 - Gangrenous (most
and Management Overview ... Ileus - Mirizzi Syndrome ... - Bouveret's Syndrome ... Diagnosis Treatment ... #Management #Treatment
Acute Coronary Syndrome - Diagnostic Likelihood Ratios for Symptoms and Physical Examination. 

Source:  Does This
Acute Coronary Syndrome ... - Diagnostic Likelihood ... Examination Systematic Review ... #EBM #Diagnosis ... #Cardiology #ACS
Acute Coronary Syndrome - Diagnostic Likelihood Ratios for Symptoms and Physical Examination. Source: Fanaroff AC, Rymer
Acute Coronary Syndrome ... - Diagnostic Likelihood ... Examination Systematic Review ... #EBM #Diagnosis ... #Cardiology #ACS
Venlafaxine. Potent SNRI approved in 1993 for the treatment of depression.

#Pharmacology #Venlaxafine #Effexor #SNRI #Overview #Review
in 1993 for the treatment ... #Pharmacology #Venlaxafine ... Effexor #SNRI #Overview ... #Review